Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4666-4672
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4666
Figure 2
Figure 2 Relationship between anti-Epstein-Barr virus IgG and B cells according to treatment in Crohn’s disease patients. Patients treated with 5-aminosalicylic acid (5-ASA) were significantly different from untreated patients (No) (Ps < 0.05). Values are expressed as mean ± SD.